{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:11:14Z","timestamp":1773267074983,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.ijrobp.2006.02.011","type":"journal-article","created":{"date-parts":[[2006,5,7]],"date-time":"2006-05-07T11:12:53Z","timestamp":1147000373000},"page":"1185-1191","source":"Crossref","is-referenced-by-count":40,"title":["Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT)"],"prefix":"10.1016","volume":"65","author":[{"given":"Benjamin D.","family":"Rosenbluth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2006.02.011_bib1","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin\u2019s lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"16","author":"Armitage","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.02.011_bib2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood.V85.4.1075.bloodjournal8541075","article-title":"A clinical analysis of two indolent lymphoma entities","volume":"85","author":"Fisher","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2006.02.011_bib3","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1182\/blood.V86.8.2892.2892","article-title":"p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32)","volume":"86","author":"Louie","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2006.02.011_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/oxfordjournals.annonc.a059154","article-title":"Mantle cell lymphoma","volume":"6","author":"Norton","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2006.02.011_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/oxfordjournals.annonc.a059156","article-title":"The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma","volume":"6","author":"Stewart","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2006.02.011_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0268-960X(05)80011-6","article-title":"Mantle cell lymphoma","volume":"8","author":"Vandenberghe","year":"1994","journal-title":"Blood Rev"},{"key":"10.1016\/j.ijrobp.2006.02.011_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.annonc.a059155","article-title":"Patterns of survival in mantle cell lymphoma","volume":"6","author":"Zucca","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2006.02.011_bib8","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/annonc\/mdg414","article-title":"Limited-stage mantle-cell lymphoma","volume":"14","author":"Leitch","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2006.02.011_bib9","doi-asserted-by":"crossref","first-page":"7905","DOI":"10.1038\/sj.onc.1206826","article-title":"Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma","volume":"22","author":"M\u2019Kacher","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2006.02.011_bib10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.leu.2401121","article-title":"Mantle cell lymphoma","volume":"12","author":"Samaha","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.ijrobp.2006.02.011_bib11","unstructured":"Zelenetz AD. Non-Hodgkin\u2019s lymphoma. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology 2005;v. 1.2005:MS-9."},{"key":"10.1016\/j.ijrobp.2006.02.011_bib12","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1200\/JCO.2003.09.542","article-title":"High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas","volume":"21","author":"Haas","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301606002690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301606002690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T14:39:01Z","timestamp":1586875141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301606002690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0360301606002690"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2006.02.011","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}